Cherington Charles (CIK 1448698) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-17). Recent activity: Buy ERNA (4.0M shares), Buy ERNA (21.2M shares), Buy ERNA (4.8M shares), Buy ERNA (261,756 shares), Buy ERNA (1.2M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 4.0M | $2.0M |
| 2025-06-11 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 21.2M | $2.1M |
| 2025-05-07 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 4.8M | $0 |
| 2025-05-07 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 261,756 | $0 |
| 2025-05-07 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 1.2M | $0 |
| 2025-05-07 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 5.4M | $0 |
| 2025-05-07 | Ernexa Therapeutics Inc. (ERNA) | 10% Owner | Buy | 1.6M | $0 |
| 2025-04-04 | Eterna Therapeutics Inc. (ERNA) | 10% Owner | Buy | 3.8M | $376,840 |
来源：SEC Form 4 申报文件 · 截至 2026-02-17